Pharmena S.A. (WSE:PHR)
3.300
-0.130 (-3.79%)
Mar 17, 2026, 5:00 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 38.2 million as of March 17, 2026. Its market cap has decreased by -23.78% in one year.
Market Cap
38.20M
Enterprise Value
30.84M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 38.20M, a decrease of -77.79%. That is a compound annual growth rate of -8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 38.20M | 31.92% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 552.57M |
| Captor Therapeutics Spolka Akcyjna | 436.77M |
| Bioceltix | 379.18M |
| BIOTON | 350.33M |
| Synthaverse | 271.76M |
| Mabion | 155.64M |
| Molecure | 129.59M |
| Poltreg | 114.25M |